Sionna Therapeutics, Inc. (SION) stock
SIONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$2.97−0.10 (-3.26%)
Close on Nov 18, 2026Market cap $134.28MP/E –Yield –
Sionna Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Sionna Therapeutics's operating cash flow for the twelve months ending Sep 30, 2026 was -$79.41M. For fiscal 2025 it was -$66.30M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$66.30M | – |
| FY2024 | Dec 31, 2024 | -$52.79M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$18.72M | – |
| Q2 FY2026 | Jun 30, 2026 | -$22.22M | – |
| Q1 FY2026 | Mar 31, 2026 | -$21.84M | – |
| Q4 FY2025 | Dec 31, 2025 | -$16.63M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15.23M | – |
| Q2 FY2025 | Jun 30, 2025 | -$18.15M | – |
| Q1 FY2025 | Mar 31, 2025 | -$16.29M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.78M | – |
| Q3 FY2024 | Sep 30, 2024 | -$17.69M | – |
| Q2 FY2024 | Jun 30, 2024 | -$10.15M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.18M | – |
See a number that looks wrong?